Experts trade barbs over ‘precision oncology’
http://www.sciencemag.org/news/2018/04/cancer-drug-tailored-your-tumor-experts-trade-barbs-over-precision-oncology?utm_campaign=news_daily_2018-04-24&et_rid=389974365&et_cid=1991622
I think you mean gene therapy at which functional gene is introduced instead of or neighboring to dysfunctional ones. Regard
Probably this will be the future. In the meantime we are overlooking very simple non taylored treatments that are less toxic and almost as effective that the sofisticated ones.
That would be a good thing, a breakthrough as oppose to what we have now that affect the good cells while destroying the bad ones.
How about energized nanoparticles that can 1) find their way into cancer cells 2) either be used with a photosensitizer drug to kill the cancer cell or have the ability to produce ionized radiation to do the same thing. The latter process can also be used on viruses, like HIV, or infectious diseases. Can alter the DNA of the pathogen.
you should see that your tumor is in which stage?
unfortunately, in developed stage, the tailoring is not beneficial.
Select agents that act on transcriptional factors including NF-kappaB, not select monoclonal antibodies such as Bevacizumab which end –mab. Monoclonal antibodies do not suppress the production of growth factors, only suppress these factors competitively.
Inhibitors that work transcriptional factors or their downstream factors suppress the production of various factors.
- Badges
- Science topic
- Similar topics
- Medicine